Skip to main content

MoneyWorks4Me

Lupin informs about press release

30 Apr 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 30th April 2020 as regards receipt of Establishment Inspection Report from the US FDA for the Company’s Pithampur Unit-1, India facility. Inspection for the said facility was conducted by the US FDA between February 3, 2020 and February 11, 2020 and concluded with two observations.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1761.95
Dr. Reddys Labs. 1344.60
Cipla 1358.00
Lupin 1994.65
Zydus Lifesciences 1176.50
View more..